Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID

15 Feb 2024

Abstract excerpt

BACKGROUND: Long COVID encompasses a heterogeneous set of ongoing symptoms that affect many individuals after recovery from infection with SARS-CoV-2. The underlying biological mechanisms nonetheless remain obscure, precluding accurate diagnosis and effective intervention. Complement dysregulation is a hallmark of acute COVID-19 but has not been investigated as a potential determinant of long COVID. METHODS: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Complement system in diseases
Share to Long-Term Effects of COVID-19
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38359836
DOI: 10.1016/j.medj.2024.01.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Complement dysregulation is a prevalent and therapeutically amenable feature of long COVIDPMID 38359836Read ↗

Complement dysregulation is a predictive and therapeutically amenable feature of long COVIDSemantic proximity Read ↗

Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID‐19Semantic proximity Read ↗

Persistent Activation of Chronic Inflammatory Pathways in Long CovidSemantic proximity Read ↗

Rationale for targeting complement in COVID‐19Semantic proximity Read ↗

Large scale phenotyping of long COVID inflammation reveals mechanistic subtypes of disease after COVID-19 hospitalisationSemantic proximity Read ↗

Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacySemantic proximity Read ↗

A complement atlas identifies interleukin-6–dependent alternative pathway dysregulation as a key druggable feature of COVID-19Semantic proximity Read ↗

Large scale phenotyping of long COVID inflammation reveals mechanistic subtypes of diseaseSemantic proximity Read ↗

Complement control for COVID-19Semantic proximity Read ↗

Complement Inhibition and COVID-19: The Story so FarSemantic proximity Read ↗

The complement system in COVID-19: friend and foe?Semantic proximity Read ↗

Identification of soluble biomarkers that associate with distinct manifestations of long COVIDSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.